These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31106706)

  • 41. Efficacy comparison of ustekinumab between anti-tumor necrosis factor-α drug-naïve and anti-tumor necrosis factor-α drug-resistant Japanese psoriasis cases.
    Takahashi N; Noda S; Taniguchi T; Adachi M
    Int J Dermatol; 2015 Oct; 54(10):1194-8. PubMed ID: 26016819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Long-term control of psoriasis is necessary].
    Sánchez Carazo JL; Martínez Casimiro L; Alegre de Miguel V
    Actas Dermosifiliogr; 2008 Jan; 99 Suppl 1():29-36. PubMed ID: 18341851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclosporine in the treatment of psoriasis.
    Gulliver WP
    Cutis; 2000 Nov; 66(5):365-9. PubMed ID: 11107522
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclosporine in Dermatology.
    Kutlubay Z; Erdogan BÇ; Engin B; Serdaroglu S
    Skinmed; 2016; 14(2):105-9. PubMed ID: 27319953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-TNF-alpha therapy in childhood pustular psoriasis.
    Pereira TM; Vieira AP; Fernandes JC; Antunes H; Basto AS
    Dermatology; 2006; 213(4):350-2. PubMed ID: 17135745
    [No Abstract]   [Full Text] [Related]  

  • 46. Combination therapy with tumor necrosis factor inhibitors in psoriasis treatment.
    Famenini S; Wu JJ
    Cutis; 2013 Sep; 92(3):140-7. PubMed ID: 24153143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Two cases of generalized pustular psoriasis complicated by IgG4-related disease.
    Miyazawa H; Fujita Y; Iwata H; Ishikawa Y; Nishio S; Ishijima K; Shinmei Y; Takeichi T; Goto K; Oi R; Akiyama M; Shimizu H
    Br J Dermatol; 2018 Aug; 179(2):537-539. PubMed ID: 29709076
    [No Abstract]   [Full Text] [Related]  

  • 48. [Biologics in the treatment of psoriasis].
    Dissemond J; Grabbe S
    MMW Fortschr Med; 2006 Sep; 148(38):42-4. PubMed ID: 17036963
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of maxacalcitol ointment on skin lesions in patients with psoriasis receiving treatment with adalimumab.
    Karakawa M; Komine M; Kishimoto M; Maki N; Matsumoto A; Sugai J; Ohtsuki M
    J Dermatol; 2016 Nov; 43(11):1354-1357. PubMed ID: 27450634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of psoriasis. Part 2. Systemic therapies.
    Lebwohl M; Ali S
    J Am Acad Dermatol; 2001 Nov; 45(5):649-61; quiz 662-4. PubMed ID: 11606913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A therapeutic approach to erythrodermic psoriasis: report of a case and a discussion of therapeutic options.
    van der Vleuten CJ; Gerritsen MJ; Steijlen PM; de Jong EM; van de Kerkhof PC
    Acta Derm Venereol; 1996 Jan; 76(1):65-7. PubMed ID: 8721498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detailed ANA dynamics under adalimumab therapy show no significant correlation to PASI response and MTX cotreatment: a retrospective study of 98 psoriasis patients.
    Hoffmann JHO; Knoop C; Enk AH; Hadaschik EN
    J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):e128-e129. PubMed ID: 30394590
    [No Abstract]   [Full Text] [Related]  

  • 53. Cyclosporine consensus conference: with emphasis on the treatment of psoriasis.
    Lebwohl M; Ellis C; Gottlieb A; Koo J; Krueger G; Linden K; Shupack J; Weinstein G
    J Am Acad Dermatol; 1998 Sep; 39(3):464-75. PubMed ID: 9738783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclosporin for atopic dermatitis in children.
    Harper JI; Berth-Jones J; Camp RD; Dillon MJ; Finlay AY; Holden CA; O'Sullivan D; Veys PA
    Dermatology; 2001; 203(1):3-6. PubMed ID: 11549791
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Generalized pustular psoriasis following withdrawal of oral cyclosporin treatment for palmo-plantar pustulosis.
    De Silva BD; Benton EC; Tidman MJ
    Clin Exp Dermatol; 1999 Jan; 24(1):10-3. PubMed ID: 10233640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brodalumab versus ustekinumab in psoriasis.
    Fioranelli M; Roccia MG; Lotti T
    Dermatol Ther; 2016 Sep; 29(5):298. PubMed ID: 26627075
    [No Abstract]   [Full Text] [Related]  

  • 57. Cyclosporine in severe psoriasis. Results of a meta-analysis in 579 patients.
    Faerber L; Braeutigam M; Weidinger G; Mrowietz U; Christophers E; Schulze HJ; Mahrle G; Meffert H; Drechsler S
    Am J Clin Dermatol; 2001; 2(1):41-7. PubMed ID: 11702620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclosporine in psoriasis: comparison of a 25-year real-world Italian experience to current European guidelines.
    Altomare G; Ayala F; Bardazzi F; Bellia G; Chimenti S; Colombo D; Flori ML; Girolomoni G; Micali G; Parodi A; Peris K; Vena GA
    G Ital Dermatol Venereol; 2016 Aug; 151(4):432-5. PubMed ID: 25786483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cancer-free survival of psoriasis patients treated with methotrexate and cyclosporine combination.
    Aydin F; Yuksel EP; Senturk N; Canturk T; Turanli AY
    Cutan Ocul Toxicol; 2014 Sep; 33(3):181-3. PubMed ID: 23944659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Generalized pustular psoriasis during pregnancy: an effective treatment with cyclosporin].
    Harvima RJ; Laukkanen A; Haring P; Rinne K
    Duodecim; 1999; 115(4):391-5. PubMed ID: 11830887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.